QTRX vs. TRNS, ALNT, LAB, EYPT, SENS, CTKB, QSI, AEHR, MASS, and FEIM
Should you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include Transcat (TRNS), Allient (ALNT), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Senseonics (SENS), Cytek Biosciences (CTKB), Quantum-Si (QSI), Aehr Test Systems (AEHR), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Quanterix vs.
Transcat (NASDAQ:TRNS) and Quanterix (NASDAQ:QTRX) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, community ranking, analyst recommendations and valuation.
Transcat has higher revenue and earnings than Quanterix. Quanterix is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
Transcat has a net margin of 6.22% compared to Quanterix's net margin of -30.12%. Transcat's return on equity of 7.23% beat Quanterix's return on equity.
98.3% of Transcat shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 6.9% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Transcat currently has a consensus price target of $111.50, indicating a potential upside of 18.16%. Quanterix has a consensus price target of $15.60, indicating a potential upside of 212.63%. Given Quanterix's stronger consensus rating and higher probable upside, analysts clearly believe Quanterix is more favorable than Transcat.
Transcat has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.
In the previous week, Quanterix had 4 more articles in the media than Transcat. MarketBeat recorded 11 mentions for Quanterix and 7 mentions for Transcat. Transcat's average media sentiment score of 0.21 beat Quanterix's score of 0.02 indicating that Transcat is being referred to more favorably in the media.
Quanterix received 62 more outperform votes than Transcat when rated by MarketBeat users. However, 65.94% of users gave Transcat an outperform vote while only 61.63% of users gave Quanterix an outperform vote.
Summary
Transcat beats Quanterix on 11 of the 18 factors compared between the two stocks.
Get Quanterix News Delivered to You Automatically
Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quanterix Competitors List
Related Companies and Tools
This page (NASDAQ:QTRX) was last updated on 5/21/2025 by MarketBeat.com Staff
